These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22955427)

  • 1. Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study.
    Nishijima T; Komatsu H; Higasa K; Takano M; Tsuchiya K; Hayashida T; Oka S; Gatanaga H
    Clin Infect Dis; 2012 Dec; 55(11):1558-67. PubMed ID: 22955427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.
    Rodríguez-Nóvoa S; Labarga P; Soriano V; Egan D; Albalater M; Morello J; Cuenca L; González-Pardo G; Khoo S; Back D; Owen A
    Clin Infect Dis; 2009 Jun; 48(11):e108-16. PubMed ID: 19400747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration.
    Ezinga M; Wetzels JF; Bosch ME; van der Ven AJ; Burger DM
    Antivir Ther; 2014; 19(8):765-71. PubMed ID: 24584104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.
    Salvaggio SE; Giacomelli A; Falvella FS; Oreni ML; Meraviglia P; Atzori C; Clementi EGI; Galli M; Rusconi S
    BMC Infect Dis; 2017 Jun; 17(1):396. PubMed ID: 28583112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction.
    Pushpakom SP; Liptrott NJ; Rodríguez-Nóvoa S; Labarga P; Soriano V; Albalater M; Hopper-Borge E; Bonora S; Di Perri G; Back DJ; Khoo S; Pirmohamed M; Owen A
    J Infect Dis; 2011 Jul; 204(1):145-53. PubMed ID: 21628669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir-induced renal tubular dysfunction in vertically HIV-infected patients associated with polymorphisms in ABCC2, ABCC4 and ABCC10 genes.
    Giacomet V; Cattaneo D; Viganò A; Nannini P; Manfredini V; Ramponi G; Clementi E; Zuccotti GV
    Pediatr Infect Dis J; 2013 Oct; 32(10):e403-5. PubMed ID: 24067562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection.
    Likanonsakul S; Suntisuklappon B; Nitiyanontakij R; Prasithsirikul W; Nakayama EE; Shioda T; Sangsajja C
    PLoS One; 2016; 11(1):e0147724. PubMed ID: 26807589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary beta-2 microglobulin and alpha-1 microglobulin are useful screening markers for tenofovir-induced kidney tubulopathy in patients with HIV-1 infection: a diagnostic accuracy study.
    Nishijima T; Shimbo T; Komatsu H; Takano M; Tanuma J; Tsukada K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
    J Infect Chemother; 2013 Oct; 19(5):850-7. PubMed ID: 23467792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study.
    Hassan MO; Duarte R; Mabayoje VO; Dickens C; Lasisi AO; Naicker S
    BMC Nephrol; 2020 Oct; 21(1):436. PubMed ID: 33066744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.
    Izzedine H; Hulot JS; Villard E; Goyenvalle C; Dominguez S; Ghosn J; Valantin MA; Lechat P; Deray AG
    J Infect Dis; 2006 Dec; 194(11):1481-91. PubMed ID: 17083032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative exposure of TDF is associated with kidney tubulopathy whether it is currently used or discontinued.
    Nishijima T; Mutoh Y; Kawasaki Y; Tomonari K; Kikuchi Y; Gatanaga H; Oka S;
    AIDS; 2018 Jan; 32(2):179-188. PubMed ID: 29028660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen.
    Manosuthi W; Sukasem C; Thongyen S; Nilkamhang S; Sungkanuparph S
    J Antimicrob Chemother; 2014 Aug; 69(8):2195-201. PubMed ID: 24788661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B.
    Shimizu M; Furusyo N; Ikezaki H; Ogawa E; Hayashi T; Ihara T; Harada Y; Toyoda K; Murata M; Hayashi J
    World J Gastroenterol; 2015 Feb; 21(7):2116-23. PubMed ID: 25717246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study.
    Nishijima T; Hayashida T; Kurosawa T; Tanaka N; Oka S; Gatanaga H
    PLoS One; 2015; 10(11):e0141931. PubMed ID: 26535588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of tenofovir treatment.
    Rodriguez-Novoa S; Labarga P; Soriano V
    Pharmacogenomics; 2009 Oct; 10(10):1675-85. PubMed ID: 19842939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.
    Rodríguez-Nóvoa S; Labarga P; D'avolio A; Barreiro P; Albalate M; Vispo E; Solera C; Siccardi M; Bonora S; Di Perri G; Soriano V
    AIDS; 2010 Apr; 24(7):1064-6. PubMed ID: 20299966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do genetic variations in proximal tubule transporters influence tenofovir-induced renal dysfunction? An exploratory study in a Ghanaian population.
    Neary M; Olagunju A; Sarfo F; Phillips R; Moss D; Owen A; Chadwick D
    J Antimicrob Chemother; 2020 May; 75(5):1267-1271. PubMed ID: 32060504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment.
    Cheli S; Baldelli S; De Silvestri A; Fusi M; Minisci D; Gervasoni C; Cattaneo D; Clementi E; Meraviglia P; Montrasio C
    Pharmacogenomics J; 2021 Oct; 21(5):586-593. PubMed ID: 33850298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of tenofovir disoproxil fumarate transporters and risk of kidney tubular dysfunction in HIV-positive patients: genetics of tenofovir transporters.
    Danjuma MI; Egan D; Abubeker IY; Post F; Khoo S
    Int J STD AIDS; 2018 Aug; ():956462418786562. PubMed ID: 30071797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients.
    Calza L; Trapani F; Tedeschi S; Piergentili B; Manfredi R; Colangeli V; Viale P
    Scand J Infect Dis; 2011 Aug; 43(8):656-60. PubMed ID: 21453205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.